Projects
-
Trends in male suicide in Canada: Policy implications2013A review of trends over time in rates and patterns of suicide in Canadian males using datasets collected by national agencies in Canada. This project is identifying key information within epidemiological data that is relevant for policy and can help guide efforts at preventing suicide and intervening awith groups who may be at high risk and in which there may be good opportunities to reduce suicide rates.
-
Crack Use Epidemiology, Harms and Interventions2012Several projects – including international project collaborations in Brazil, principally with academic partners in Rio de Janeiro, Sao Paulo and Salvador - investigate the epidemiology of crack use and related health and social harms, as well as effective prevention (e.g., public health interventions like safer crack use paraphernalia distribution) and treatment interventions (e.g., novel pharmacotherapy treatments) for crack use in different jurisdictions.
-
Knowledge Translation in Healthcare: The I2I2012In partnership with the Mental Health Commission of Canada, CARMHA developed the I2I (Innovation To Implementation) workbook, a step-by-step guide to implementing knowledge translation in healthcare.
-
Public Health Interventions, Regulation and Control for Cannabis2012This program – with both a Canadian and international focus - consists of project components investigating the feasibility and outcomes of public health interventions for cannabis use (e.g., ‘Lower Risk Cannabis Use Guidelines’, Brief Interventions for High-Frequency Cannabis Use). It also focuses on the development and evaluation of evidence-based policy options and frameworks for public health oriented regulation and control of both personal cannabis use as well as cannabis supply.
-
Prescription Opioid Misuse, Harms and Interventions2012Comprised of several research projects focusing both on North America and other global regions, key activities in this domestic and international program investigate: the epidemiology of non-medical prescription opioid use (NMPOU) in general and special risk populations; epidemiology and determinants; PO-related morbidity, mortality and burden of disease; PO diversion and NMPOU sources/supply routes; evidence-based prevention, treatment and policy interventions for PO harms.